Shoulder Innovations (SI) Cash from Investing Activities (2024 - 2026)
Shoulder Innovations' (SI) quarterly Cash from Investing Activities came in at $20.4 million in Q2 2026, up 184.3% on a YoY basis from $7.2 million in Q2 2025, and up 754.84% quarter-over-quarter from -$3.1 million in Q1 2026.
Analysis
Shoulder Innovations (SI) Cash from Investing Activities (2024 - 2026) Analysis & Trends
Shoulder Innovations (SI) has reported Cash from Investing Activities for 3 consecutive years, with $20.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities rose 184.3% year-over-year to $20.4 million; the trailing twelve-month figure through Jun 2026 stood at -$72.4 million (down 2806.39% YoY), and the FY2025 full-year result was -$95.6 million, down 784.6% from the prior year.
- Cash from Investing Activities improved to $20.4 million in Q2 2026 per SI's latest filing, from -$3.1 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $20.4 million in Q2 2026 and bottomed at -$72.4 million in Q3 2025.
- Historically, Cash from Investing Activities has averaged -$8.7 million across 3 years, with a median of $264000.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities slumped 1577.08% in 2025, then soared 184.3% in 2026.
- Over 3 years, Cash from Investing Activities stood at $3.6 million in 2024, then plunged by 573.48% to -$17.3 million in 2025, then surged by 218.3% to $20.4 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered $20.4 million, -$3.1 million, and -$17.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 185.05 Bn | 179.45 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 124.43 Bn | 119.22 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 118.52 Bn | 109.70 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 104.55 Bn | 101.07 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 67.11 Bn | 66.57 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.85 Bn | 45.60 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.97 Bn | 32.52 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.15 Bn | 20.67 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Shoulder Innovations | 413.68 Mn | 314.68 Mn | 13.44 Mn | 20.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.44 Mn |
| Mar 31, 2026 | -3.12 Mn |
| Dec 31, 2025 | -17.28 Mn |
| Sep 30, 2025 | -72.44 Mn |
| Jun 30, 2025 | 7.19 Mn |
| Mar 31, 2025 | -13.07 Mn |
| Dec 31, 2024 | 3.65 Mn |
| Sep 30, 2024 | 4.90 Mn |